Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04079660 · ClinicalTrials.gov registry record
Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 50
- Enrollment target
NCT04079660: Completed study, sponsored by Ohio State University.
NCT04079660 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04079660 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Diabetes mellitus is associated with negative outcomes in patients undergoing surgery. Blood sugar levels are monitored by measuring a values that include but are not limited to hemoglobin A1c, capillary blood glucose, and fructosamine . This study is being done to investigate if there is an associated between these values and postsurgical outcomes.
Primary Outcome
Association between pre-operative HbA1c and fructosamine with pre-operative, fasting capillary blood glucose level measured the morning of surgery in preoperative holding area.
Interventions
- DIAGNOSTIC_TEST Capillary blood glucose blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-02-01 |
What the finished NCT04079660 record still lists
NCT04079660 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Capillary blood glucose blood draw is the first listed.
NCT04079660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04079660 about?
NCT04079660 is a clinical study titled "Glycemic Control Based on Serum Fructosamine Concentration vs. hemoglobinA1c (HbA1c) in Diabetic Patients". Diabetes mellitus is associated with negative outcomes in patients undergoing surgery. Blood sugar levels are monitored by measuring a values that include but are not limited to hemoglobin A1c, capillary blood glucose, and fructosamine . This study is being done to investigate if there is an associa...
What is the current status of trial NCT04079660?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2021-02-01. Estimated completion is 2021-02-01.
What interventions are being tested in trial NCT04079660?
The interventions under investigation include: Capillary blood glucose blood draw (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04079660?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI